https://www.selleckchem.com/pr....oducts/ly3023414.htm
Therefore, the use of DMA in humans must be closely monitored.Introduction Optimal anticoagulation for left ventricular assist device recipients aims to balance thrombosis and bleeding complications. Routine plasma-based coagulation tests may not accurately reflect overall hemostasis, and surrogate markers are used to help guide clinicians in the diagnosis of pump thrombosis. Thromboelastography derived coagulation index (CI) has been shown to be a parameter that can reflect "normocoagulability" in mechanical circulatory support devic
Curtir
Comentario
Compartilhar
